We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Dengue Virus Specific T-Cell Responses Correlated with Disease Severity

By LabMedica International staff writers
Posted on 04 Dec 2018
Dengue virus (DENV) is the cause of the most common mosquito-borne viral infection worldwide, and over half of the global population live in areas where there is intense dengue transmission putting them at risk of dengue infection.

Dengue virus causes 390 million infections annually, of which nearly a quarter are clinically apparent causing a spectrum of disease phenotypes ranging from mild dengue fever (DF) to dengue hemorrhagic fever (DHF). More...
DHF is defined by a transient increase in vascular permeability resulting in plasma leakage, with high fever, bleeding, thrombocytopenia and haemoconcentration, which can lead to dengue shock syndrome (DSS).

Scientists at the University of Sri Jayewardenepura (Nugegoda, Sri Lanka) and their colleagues recruited 74 adult patients with acute dengue infection with between days four to eight of illness. Patients with ultrasound scan evidence of plasma leakage (those who had pleural effusions or ascites) were classified as having DHF, 45 patients had DHF and 29 patients had dengue fever (DF) of the 74 patients recruited for the study.

Acute dengue infection was confirmed in serum samples using polymerase chain reactions (PCR) and dengue antibody detection. Dengue antibody assays were completed using a commercial capture-IgM and IgG ELISA. RNA was extracted from the serum samples and multiplex quantitative real-time PCR was performed as previously described using the CDC real time PCR assay for detection of the dengue virus, and modified to quantify the DENV.

The team used ex vivo IFNγ ELISpot assays and determined the frequency of dengue viral peptide (DENV)-NS3, NS1 and NS5 responsive T cells in 74 adult patients with acute dengue infection and examined the association of responsive T cell frequency with the extent of viremia and clinical disease severity. The spots were enumerated using an automated ELISpot reader.

The team reported that found that total DENV-specific and DENV-NS3-specific T cell responses, were higher in patients with dengue fever (DF), when compared to those with dengue hemorrhagic fever (DHF). In addition, those with DF had significantly higher DENV-specific T cell responses on day four of infection compared to those who subsequently developed DHF. DENV peptide specific T cell responses inversely correlated with the degree of viremia, which was most significant for DENV-NS3 specific T cell responses. The frequency of T cell responses to NS1, NS5 and pooled DENV peptides, correlated with the degree of thrombocytopenia but had no association with levels of liver transaminases. In contrast, total DENV-IgG inversely correlated with the degree of thrombocytopenia and levels of liver transaminases.

The authors concluded that early appearance of DENV-specific T cell IFNγ responses before the onset of plasma leakage appears to associate with milder clinical disease and resolution of viremia, suggesting a protective role in acute dengue infection. The study was published on October 1, 2018, in the journal Public Library of Science Neglected Tropical Diseases.

Related Links:
University of Sri Jayewardenepura


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Electrolyte Analyzer
CBS-4000 (CBS-400)
Thyroid Test
Anti-Thyroid EIA Test
New
Gastrointestinal Panel
Xpert® GI Panel
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: iStock

Prehospital Blood Test Could Reduce Emergency Transfers for Chest Pain

Chest pain leads to ambulance transport to an emergency department for about 95% of patients, although only a minority have a serious cardiac condition. Troponin testing helps assess heart muscle damage,... Read more

Molecular Diagnostics

view channel
Image: Many patients with atopic dermatitis modify systemic therapy because of inadequate efficacy, highlighting the need for molecular tools and biomarkers to guide treatment selection. (Image Credit: iStock)

Molecular Skin Test May Help Guide Treatment Selection in Atopic Dermatitis

Patients with atopic dermatitis (eczema) often struggle to achieve consistent symptom control, leading many to alter or switch systemic therapies when treatment is ineffective. Newly published survey data... Read more

Microbiology

view channel
Image: Each PhAST instrument supports random-access processing of up to four samples simultaneously, delivering a throughput of up to 12 samples per eight-hour shift. (Photo courtesy of PhAST)

FDA Clears Rapid Phenotypic Antimicrobial Susceptibility System for Positive Blood Cultures

Bloodstream infections require prompt treatment, but antimicrobial susceptibility results often lag behind a positive blood culture. Conventional testing can take another 24 to 48 hours after a culture... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.